Biorem Inc
XTSX:BRM
Balance Sheet
Balance Sheet Decomposition
Biorem Inc
Biorem Inc
Balance Sheet
Biorem Inc
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
0
|
4
|
2
|
2
|
4
|
1
|
2
|
2
|
2
|
1
|
3
|
1
|
4
|
4
|
6
|
9
|
4
|
4
|
2
|
5
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2
|
0
|
4
|
2
|
2
|
4
|
1
|
1
|
2
|
2
|
1
|
3
|
1
|
4
|
4
|
6
|
9
|
4
|
4
|
2
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
3
|
5
|
4
|
4
|
9
|
6
|
10
|
6
|
5
|
5
|
4
|
5
|
9
|
11
|
13
|
6
|
8
|
10
|
12
|
15
|
15
|
|
| Accounts Receivables |
3
|
5
|
4
|
4
|
9
|
6
|
10
|
6
|
5
|
5
|
4
|
5
|
9
|
11
|
13
|
6
|
8
|
10
|
12
|
15
|
15
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
3
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Total Current Assets |
6
|
7
|
9
|
7
|
13
|
11
|
12
|
9
|
9
|
8
|
7
|
9
|
11
|
16
|
18
|
14
|
18
|
16
|
18
|
21
|
25
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| PP&E Gross |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
4
|
4
|
4
|
|
| Intangible Assets |
0
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
|
| Other Assets |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
12
+89%
|
15
+22%
|
12
-21%
|
17
+47%
|
15
-11%
|
16
+4%
|
10
-34%
|
10
-6%
|
9
-9%
|
8
-14%
|
9
+21%
|
11
+22%
|
16
+38%
|
21
+34%
|
18
-16%
|
22
+25%
|
19
-13%
|
21
+8%
|
24
+16%
|
29
+18%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
2
|
3
|
3
|
3
|
5
|
2
|
4
|
3
|
3
|
2
|
2
|
2
|
3
|
4
|
4
|
2
|
2
|
5
|
5
|
6
|
4
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
4
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
3
|
3
|
3
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
4
|
2
|
3
|
2
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
2
|
1
|
2
|
2
|
3
|
3
|
2
|
2
|
3
|
4
|
4
|
5
|
8
|
|
| Total Current Liabilities |
3
|
3
|
3
|
3
|
6
|
4
|
10
|
10
|
7
|
8
|
7
|
7
|
9
|
8
|
8
|
6
|
8
|
13
|
13
|
14
|
15
|
|
| Long-Term Debt |
2
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
3
|
3
|
|
| Total Liabilities |
5
N/A
|
3
-30%
|
3
-2%
|
3
-8%
|
8
+171%
|
7
-19%
|
10
+55%
|
10
-5%
|
10
0%
|
8
-17%
|
8
-1%
|
7
-7%
|
9
+21%
|
8
-6%
|
8
-3%
|
6
-28%
|
8
+43%
|
17
+104%
|
16
-6%
|
17
+7%
|
18
+3%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
3
|
10
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
14
|
14
|
17
|
17
|
17
|
17
|
5
|
5
|
5
|
5
|
|
| Retained Earnings |
2
|
1
|
2
|
5
|
6
|
6
|
9
|
14
|
15
|
14
|
16
|
14
|
14
|
12
|
8
|
9
|
7
|
6
|
4
|
2
|
1
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Total Equity |
2
N/A
|
9
+450%
|
11
+31%
|
9
-25%
|
9
+3%
|
9
-3%
|
6
-35%
|
1
-89%
|
0
-92%
|
1
+1 660%
|
0
N/A
|
2
N/A
|
2
+26%
|
7
+201%
|
13
+77%
|
12
-9%
|
14
+15%
|
2
-85%
|
5
+130%
|
7
+49%
|
11
+58%
|
|
| Total Liabilities & Equity |
6
N/A
|
12
+89%
|
15
+22%
|
12
-21%
|
17
+47%
|
15
-11%
|
16
+4%
|
10
-34%
|
10
-6%
|
9
-9%
|
8
-14%
|
9
+21%
|
11
+22%
|
16
+38%
|
21
+34%
|
18
-16%
|
22
+25%
|
19
-13%
|
21
+8%
|
24
+16%
|
29
+18%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
2
|
10
|
12
|
12
|
12
|
12
|
12
|
13
|
13
|
13
|
13
|
15
|
16
|
38
|
39
|
39
|
39
|
15
|
15
|
16
|
16
|
|